Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain - PubMed (original) (raw)
Review
Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain
P L Golden et al. Cell Mol Neurobiol. 2000 Apr.
Abstract
1. P-Glycoprotein is a 170-kDa transmembrane glycoprotein active efflux system that confers multidrug resistance in tumors, as well as normal tissues including brain. 2. The classical model of multidrug resistance in brain places the expression of P-glycoprotein at the luminal membrane of the brain microvascular endothelial cell. However, recent studies have been performed with human brain microvessels and double-labeling confocal microscopy using (a) the MRK16 antibody to human P-glycoprotein, (b) an antiserum to glial fibrillary acidic protein (GFAP), an astrocyte foot process marker, or (c) an antiserum to the GLUT1 glucose transporter, a brain endothelial plasma membrane marker. These results provide evidence for a revised model of P-glycoprotein function at the brain microvasculature. In human brain capillaries, there is colocalization of immunoreactive P-glycoprotein with astrocytic GFAP but not with endothelial GLUT1 glucose transporter. 3. In the revised model of multidrug resistance in brain, P-glycoprotein is hypothesized to function at the plasma membrane of astrocyte foot processes. These astrocyte foot processes invest the brain microvascular endothelium but are located behind the blood-brain barrier in vivo, which is formed by the brain capillary endothelial plasma membrane. 4. In the classical model, an inhibition of endothelial P-glycoprotein would result in both an increase in the blood-brain barrier permeability to a given drug substrate of P-glycoprotein and an increase in the brain volume of distribution (VD) of the drug. However, in the revised model of P-glycoprotein function in brain, which positions this protein transporter at the astrocyte foot process, an inhibition of P-glycoprotein would result in no increase in blood-brain barrier permeability, per se, but only an increase in the VD in brain of P-glycoprotein substrates.
Similar articles
- Brain microvascular and astrocyte localization of P-glycoprotein.
Pardridge WM, Golden PL, Kang YS, Bickel U. Pardridge WM, et al. J Neurochem. 1997 Mar;68(3):1278-85. doi: 10.1046/j.1471-4159.1997.68031278.x. J Neurochem. 1997. PMID: 9048775 - P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries.
Golden PL, Pardridge WM. Golden PL, et al. Brain Res. 1999 Feb 20;819(1-2):143-6. doi: 10.1016/s0006-8993(98)01305-5. Brain Res. 1999. PMID: 10082869 - Microvascular P-glycoprotein expression at the blood-brain barrier following focal astrocyte loss and at the fenestrated vasculature of the area postrema.
Willis CL, Taylor GL, Ray DE. Willis CL, et al. Brain Res. 2007 Oct 10;1173:126-36. doi: 10.1016/j.brainres.2007.07.074. Epub 2007 Aug 15. Brain Res. 2007. PMID: 17803981 - Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.
Demeule M, Régina A, Jodoin J, Laplante A, Dagenais C, Berthelet F, Moghrabi A, Béliveau R. Demeule M, et al. Vascul Pharmacol. 2002 Jun;38(6):339-48. doi: 10.1016/s1537-1891(02)00201-x. Vascul Pharmacol. 2002. PMID: 12529928 Review. - Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R, Lee G, Bendayan M. Bendayan R, et al. Microsc Res Tech. 2002 Jun 1;57(5):365-80. doi: 10.1002/jemt.10090. Microsc Res Tech. 2002. PMID: 12112443 Review.
Cited by
- Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.
Prokai-Tatrai K, Prokai L. Prokai-Tatrai K, et al. Molecules. 2009 Feb 6;14(2):633-54. doi: 10.3390/molecules14020633. Molecules. 2009. PMID: 19214153 Free PMC article. Review. - Advancing brain barriers RNA sequencing: guidelines from experimental design to publication.
Francisco DMF, Marchetti L, Rodríguez-Lorenzo S, Frías-Anaya E, Figueiredo RM; BtRAIN Network; Winter P, Romero IA, de Vries HE, Engelhardt B, Bruggmann R. Francisco DMF, et al. Fluids Barriers CNS. 2020 Aug 18;17(1):51. doi: 10.1186/s12987-020-00207-2. Fluids Barriers CNS. 2020. PMID: 32811511 Free PMC article. Review. - The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.
Westerhout J, Smeets J, Danhof M, de Lange EC. Westerhout J, et al. J Pharmacokinet Pharmacodyn. 2013 Jun;40(3):327-42. doi: 10.1007/s10928-013-9314-4. Epub 2013 Mar 29. J Pharmacokinet Pharmacodyn. 2013. PMID: 23539188 Free PMC article. - Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain.
Yu ZY, Ono S, Spatz M, McCarron RM. Yu ZY, et al. Neurochem Res. 2002 Dec;27(12):1625-32. doi: 10.1023/a:1021630926302. Neurochem Res. 2002. PMID: 12515315 - Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.
Spiegl-Kreinecker S, Buchroithner J, Elbling L, Steiner E, Wurm G, Bodenteich A, Fischer J, Micksche M, Berger W. Spiegl-Kreinecker S, et al. J Neurooncol. 2002 Mar;57(1):27-36. doi: 10.1023/a:1015735815111. J Neurooncol. 2002. PMID: 12125964
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous